Identification of a Biomarker Profile Associated With Resistance to Neoadjuvant Chemoradiation Therapy in Rectal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of a Biomarker Profile Associated With Resistance to Neoadjuvant Chemoradiation Therapy in Rectal Cancer

Published:2011-09 Issue:3 Volume:254 Page:486-493
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Garcia-Aguilar Julio,Chen Zhenbin,Smith David D.,Li Wenyan,Madoff Robert D.,Cataldo Peter,Marcet Jorge,Pastor Carlos

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference50 articles.

1. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.;Peeters;Ann Surg,2007

2. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy.;Merchant;J Gastrointest Surg,1999

3. Total rectal resection, mesorectum excision, and coloendoanal anastomosis: a therapeutic option for the treatment of low rectal cancer.;Leo;Ann Surg Oncol,1996

4. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence Br J Surg.;Heald,1982

5. Abdominoperineal resection for rectal cancer: historic perspective and current issues.;Chessin;Surg Oncol Clin N Am,2005

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B7H3 Immune Checkpoint Overexpression Is Associated with Decreased Complete Response Rates to Neoadjuvant Therapy in Locally Advanced Rectal Cancer;Diagnostics;2024-09-12

2. A Review of Neoadjuvant Therapy and the Watch-and-Wait Protocol in Rectal Cancer: Current Evidence and Future Directions;Cureus;2024-09-02

3. Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma;BMC Gastroenterology;2024-08-13

4. Genetic profiling in radiotherapy: a comprehensive review;Frontiers in Oncology;2024-07-26

5. Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancer;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3